mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |